Keywords: genentech, extends, stock, repurchase, plan, biotechnology, firm

Genentech extends stock repurchase plan

Article | 01 May 2006

Print This

US biotechnology firm Genentech, which is majority-owned by Swiss drug major Roche, says that its board of directors has authorized ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in